Advertisement

Menopause, Aging, Pelvic Organ Prolapse, and Dysfunction

  • Silvia Pisaneschi
  • Giulia Palla
  • Stefania Spina
  • Guja Bernacchi
  • Elena Cecchi
  • Silvia Di Bello
  • Magdalena Montt Guevara
  • Adrian Campelo
  • Tommaso SimonciniEmail author
Part of the ISGE Series book series (ISGE)

Abstract

The female pelvic floor is a complex functional unit involved in many undertakings.

Pelvic floor dysfunction affects micturition, defecation, and sexual activity. Evolutionary adaptation, such as the acquisition of the upright standing position, walking, and delivery of fetuses with larger head diameters, made the fascial and the muscle support of the pelvic floor more vulnerable, predisposing women to pelvic organ prolapse and incontinence.

In addition, the female pelvic floor (differently than in males) undergoes a number of adaptive changes related to life and endocrine events. Many of these clinical manifestations become apparent after menopause and aging in women.

This chapter summarizes the key aspects of the pathophysiology and the clinics of the changes of the pelvic floor in women, in particular focusing on the association between endocrine changes of aging women and urinary problems and bowel dysfunctions.

Keywords

Urinary Incontinence Irritable Bowel Syndrome Pelvic Floor Stress Urinary Incontinence Pelvic Organ Prolapse 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Haylen BT et al (2010) An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 29(1):4–20PubMedGoogle Scholar
  2. 2.
    Swift SE, Tate SB, Nicholas J (2003) Correlation of symptoms with degree of pelvic organ support in a general population of women: what is pelvic organ prolapse? Am J Obstet Gynecol 189(2):372–377, discussion 377–379PubMedCrossRefGoogle Scholar
  3. 3.
    Hendrix SL et al (2002) Pelvic organ prolapse in the Women’s Health Initiative: gravity and gravidity. Am J Obstet Gynecol 186(6):1160–1166PubMedCrossRefGoogle Scholar
  4. 4.
    Handa VL et al (2004) Progression and remission of pelvic organ prolapse: a longitudinal study of menopausal women. Am J Obstet Gynecol 190(1):27–32PubMedCrossRefGoogle Scholar
  5. 5.
    Nygaard I, Bradley C, Brandt D (2004) Pelvic organ prolapse in older women: prevalence and risk factors. Obstet Gynecol 104(3):489–497PubMedCrossRefGoogle Scholar
  6. 6.
    Bradley CS et al (2007) Natural history of pelvic organ prolapse in postmenopausal women. Obstet Gynecol 109(4):848–854PubMedCrossRefGoogle Scholar
  7. 7.
    Rortveit G et al (2007) Symptomatic pelvic organ prolapse: prevalence and risk factors in a population-based, racially diverse cohort. Obstet Gynecol 109(6):1396–1403PubMedCrossRefGoogle Scholar
  8. 8.
    Nygaard I et al (2008) Prevalence of symptomatic pelvic floor disorders in US women. JAMA 300(11):1311–1316PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Melville JL et al (2005) Urinary incontinence in US women: a population-based study. Arch Intern Med 165(5):537–542PubMedCrossRefGoogle Scholar
  10. 10.
    Irwin DE et al (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50(6):1306–1314, discussion 1314–1315PubMedCrossRefGoogle Scholar
  11. 11.
    Bove A et al (2012) Consensus statement AIGO/SICCR: diagnosis and treatment of chronic constipation and obstructed defecation (part I: diagnosis). World J Gastroenterol 18(14):1555–1564PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Bosshard W et al (2004) The treatment of chronic constipation in elderly people: an update. Drugs Aging 21(14):911–930PubMedCrossRefGoogle Scholar
  13. 13.
    Bharucha AE et al (2013) American Gastroenterological Association medical position statement on constipation. Gastroenterology 144(1):211–217PubMedCrossRefGoogle Scholar
  14. 14.
    Murad-Regadas S et al (2009) Defecographic pelvic floor abnormalities in constipated patients: does mode of delivery matter? Tech Coloproctol 13(4):279–283PubMedCrossRefGoogle Scholar
  15. 15.
    McCrea GL et al (2008) Pathophysiology of constipation in the older adult. World J Gastroenterol 14(17):2631–2638PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Hosia-Randell H et al (2007) Use of laxatives among older nursing home residents in Helsinki, Finland. Drugs Aging 24(2):147–154PubMedCrossRefGoogle Scholar
  17. 17.
    Rao SS, Go JT (2010) Update on the management of constipation in the elderly: new treatment options. Clin Interv Aging 5:163–171PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Basson R et al (2000) Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 163(3):888–893PubMedCrossRefGoogle Scholar
  19. 19.
    Soderberg MW et al (2007) Pelvic floor sex steroid hormone receptors, distribution and expression in pre- and postmenopausal stress urinary incontinent women. Acta Obstet Gynecol Scand 86(11):1377–1384PubMedCrossRefGoogle Scholar
  20. 20.
    Dietz HP, Tekle H, Williams G (2012) Pelvic floor structure and function in women with vesicovaginal fistula. J Urol 188(5):1772–1777PubMedCrossRefGoogle Scholar
  21. 21.
    Goepel C (2008) Differential elastin and tenascin immunolabeling in the uterosacral ligaments in postmenopausal women with and without pelvic organ prolapse. Acta Histochem 110(3):204–209PubMedCrossRefGoogle Scholar
  22. 22.
    Fitzpatrick CC, Elkins TE, DeLancey JO (1996) The surgical anatomy of needle bladder neck suspension. Obstet Gynecol 87(1):44–49PubMedCrossRefGoogle Scholar
  23. 23.
    Badiou W et al (2008) Comparative histological analysis of anterior vaginal wall in women with pelvic organ prolapse or control subjects. A pilot study. Int Urogynecol J Pelvic Floor Dysfunct 19(5):723–729PubMedCrossRefGoogle Scholar
  24. 24.
    Chen BH et al (2002) Collagen metabolism and turnover in women with stress urinary incontinence and pelvic prolapse. Int Urogynecol J Pelvic Floor Dysfunct 13(2):80–87, discussion 87PubMedCrossRefGoogle Scholar
  25. 25.
    Boreham MK et al (2002) Morphometric analysis of smooth muscle in the anterior vaginal wall of women with pelvic organ prolapse. Am J Obstet Gynecol 187(1):56–63PubMedCrossRefGoogle Scholar
  26. 26.
    DeLancey JO et al (2007) Comparison of levator ani muscle defects and function in women with and without pelvic organ prolapse. Obstet Gynecol 109(2 Pt 1):295–302PubMedCrossRefGoogle Scholar
  27. 27.
    De Blok S (1982) The connective tissue of the adult female pelvic region. A dissectional analysis. Acta Morphol Neerl Scand 20(2):191–212PubMedGoogle Scholar
  28. 28.
    Pinkerton JH (1973) Some aspects of the evolution and comparative anatomy of the human pelvis. J Obstet Gynaecol Br Commonw 80(2):97–102PubMedCrossRefGoogle Scholar
  29. 29.
    Jackson SR et al (1996) Changes in metabolism of collagen in genitourinary prolapse. Lancet 347(9016):1658–1661PubMedCrossRefGoogle Scholar
  30. 30.
    Falconer C et al (1998) Different organization of collagen fibrils in stress-incontinent women of fertile age. Acta Obstet Gynecol Scand 77(1):87–94PubMedCrossRefGoogle Scholar
  31. 31.
    Enhorning GE (1976) A concept of urinary continence. Urol Int 31(1–2):3–5PubMedCrossRefGoogle Scholar
  32. 32.
    Sartori MG et al (2011) Sexual steroids in urogynecology. Climacteric 14(1):5–14PubMedCrossRefGoogle Scholar
  33. 33.
    Rud T et al (1980) Factors maintaining the intraurethral pressure in women. Invest Urol 17(4):343–347PubMedGoogle Scholar
  34. 34.
    Jarmy-Di Bella ZI et al (2000) Power Doppler of the urethra in continent or incontinent, pre- and postmenopausal women. Int Urogynecol J Pelvic Floor Dysfunct 11(3):148–154, discussion 154–155PubMedCrossRefGoogle Scholar
  35. 35.
    Bruce D, Rymer J (2009) Symptoms of the menopause. Best Pract Res Clin Obstet Gynaecol 23(1):25–32PubMedCrossRefGoogle Scholar
  36. 36.
    Bygdeman M, Swahn ML (1996) Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women. Maturitas 23(3):259–263PubMedCrossRefGoogle Scholar
  37. 37.
    Gebhart JB et al (2001) Expression of estrogen receptor isoforms alpha and beta messenger RNA in vaginal tissue of premenopausal and postmenopausal women. Am J Obstet Gynecol 185(6):1325–1330, discussion 1330–1331PubMedCrossRefGoogle Scholar
  38. 38.
    Xie Z et al (2007) Alterations of estrogen receptor-alpha and -beta in the anterior vaginal wall of women with urinary incontinence. Eur J Obstet Gynecol Reprod Biol 134(2):254–258PubMedCrossRefGoogle Scholar
  39. 39.
    Robinson D, Cardozo LD (2003) The role of estrogens in female lower urinary tract dysfunction. Urology 62(4 Suppl 1):45–51PubMedCrossRefGoogle Scholar
  40. 40.
    Aikawa K et al (2003) The effect of ovariectomy and estradiol on rabbit bladder smooth muscle contraction and morphology. J Urol 170(2 Pt 1):634–637PubMedCrossRefGoogle Scholar
  41. 41.
    Zoubina EV et al (2001) Acute and chronic estrogen supplementation decreases uterine sympathetic innervation in ovariectomized adult virgin rats. Histol Histopathol 16(4):989–996PubMedGoogle Scholar
  42. 42.
    Blakeman PJ, Hilton P, Bulmer JN (2000) Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to oestrogen status. BJU Int 86(1):32–38PubMedCrossRefGoogle Scholar
  43. 43.
    Hextall A et al (2001) The impact of the menstrual cycle on urinary symptoms and the results of urodynamic investigation. BJOG : Int J Obstet Gynaecol 108(11):1193–1196Google Scholar
  44. 44.
    Lawrence JM et al (2008) Prevalence and co-occurrence of pelvic floor disorders in community-dwelling women. Obstet Gynecol 111(3):678–685PubMedCrossRefGoogle Scholar
  45. 45.
    Ismail SI, Bain C, Hagen S (2010) Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women. Cochrane Database Syst Rev 9, CD007063PubMedGoogle Scholar
  46. 46.
    Nappi RE, Davis SR (2012) The use of hormone therapy for the maintenance of urogynecological and sexual health post WHI. Climacteric 15(3):267–274PubMedCrossRefGoogle Scholar
  47. 47.
    Shenfeld OZ et al (1999) Rapid effects of estrogen and progesterone on tone and spontaneous rhythmic contractions of the rabbit bladder. Urol Res 27(5):386–392PubMedCrossRefGoogle Scholar
  48. 48.
    Gallagher P, O'Mahony D (2009) Constipation in old age. Best Pract Res Clin Gastroenterol 23(6):875–887PubMedCrossRefGoogle Scholar
  49. 49.
    Rociu E et al (2000) Normal anal sphincter anatomy and age- and sex-related variations at high-spatial-resolution endoanal MR imaging. Radiology 217(2):395–401PubMedCrossRefGoogle Scholar
  50. 50.
    McFarland LV, Dublin S (2008) Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol 14(17):2650–2661PubMedCentralPubMedCrossRefGoogle Scholar
  51. 51.
    Murad-Regadas SM et al (2012) The influence of age on posterior pelvic floor dysfunction in women with obstructed defecation syndrome. Tech Coloproctol 16(3):227–232PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2014

Authors and Affiliations

  • Silvia Pisaneschi
    • 1
  • Giulia Palla
    • 1
  • Stefania Spina
    • 1
  • Guja Bernacchi
    • 1
  • Elena Cecchi
    • 1
  • Silvia Di Bello
    • 1
  • Magdalena Montt Guevara
    • 1
  • Adrian Campelo
    • 1
  • Tommaso Simoncini
    • 1
    Email author
  1. 1.Division of Obstetrics and Gynecology, Department of Clinical and Experimental MedicineUniversity of PisaPisaItaly

Personalised recommendations